蘇州高新(600736.SH):擬對東菱振動增資24957萬元 為其擴大研發投入提供資金支持
格隆匯11月19日丨蘇州高新(600736.SH)公佈,東菱振動為公司全資子公司,為加大研發投資力度,加強產學研深度合作,擴大生產經營規模,進一步提升品牌知名度及競爭力,公司擬對東菱振動增資24957萬元,增資價格為4.23元/註冊資本份額,其中5900萬元計入註冊資本,19057萬元計入資本公積;增資完成後,東菱振動的註冊資本由2100萬元增至8000萬元。
東菱振動業務範圍涵蓋高端裝備製造、測試試驗服務、軟件開發和系統集成,此次增資能夠為其擴大研發投入提供資金支持,進一步佔據振動領域的技術制高點,增加戰略新興產業在公司營收和利潤的佔比,優化產業結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.